Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Nominations Committees’ Resolutions Series: #1- Board and Executive Succession Planning Must Be Forward Looking

Succession Planning should concern the nomination committee all year round, but the ticking over of the calendar is the perfect opportunity to appraise the sophistication of your succession planning. In late 2015, the FRC published its Guidance on Board Succession … Continue reading

Posted in Corporate Governance | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Third Rock Ventures Recruits Industry Heavyweight Michael Bonney

Boston based venture capital powerhouse Third Rock Ventures, have announced the appointment of Michael W. Bonney as partner. Mr. Bonney was previously the CEO of Cubist Pharmaceuticals until its acquisition by Merck & Co. Mr. Bonney brings to Third Rock … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , | Leave a comment

Codiak BioSciences Begins to Appoint Executives to Leadership Team

Codiak BioSciences, a venture-backed start-up in Cambridge, Mass, has appointed Ariel Jasie as Chief Business Officer, Linda Bain as CFO and Konstantin Konstantinov as Senior Vice President. “They all bring critical expertise and leadership experience to Codiak as we build … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , , , , | Leave a comment

Women Executives: Stepping Up to the C-suite and Board (Event Schedule)

Event Date:  Thursday, December 3, 2015 from 4:00 PM to 7:30 PM (EST) Event Location:  Biogen, Bio-9 Building, 300 Binney Street Cambridge, MA 02142 – View Map Register FREE for the event here Download the Event Invitation Flyer In biotechnology companies, … Continue reading

Posted in Board Director Appointments, Corporate Governance, Workplace Diversity | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Board Appointment for IPO-ready Dimension Therapeutics

Just days after setting the terms for its pending IPO, Dimension Therapeutics, Inc., a leading rare disease company advancing novel, liver-directed treatments for diverse genetic disorders,  announced the election of Alan B. Colowick, M.D., M.P.H., Executive Vice President of Celgene … Continue reading

Posted in Board Director Appointments | Tagged , , , , , , , , , , , | Leave a comment

Celgene Board Diversifies Above Key 30% Mark

Celgene has announced the appointment of Julia Haller, M.D, to the Board of Directors. The appointment means Celgene now has three females on the board and reaches a 33% ratio of women non-executive board directors, a critical mass that is … Continue reading

Posted in Board Director Appointments, Workplace Diversity | Tagged , , , , , , , , | Leave a comment

Biotech M&A Continues to Climb the Curve

The trajectory of biotech M&A has been steep in 2015, so the $7.2bn acquisition of Receptos by oncology powerhouse Celgene, increases the gradient even further. This deal came out of left field, especially as commentators were still raking over the … Continue reading

Posted in M&A Finance and Funding, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Third Rock Ventures shows promise with early stage investment strategy

Authored by Karl Simpson – April 2013 When the biotechnology industry’s great and good assemble in Chicago for BIO this week, few there will have had such an illustrious beginning to the year as Mark Levin’s Boston based Third Rock Ventures. … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

Sutro Biopharma signs $1bn deal with Celgene

Authored by James Sheppard The San Francisco based biotech company Sutro Biopharma announced that it has signed a multi-year strategic collaboration and option to acquire agreement with the global biotech company Celgene. The deal follows an agreement signed between the … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , | Leave a comment

Celgene and BMS team up for cancer immunotherapy development

Authored by James Sheppard The two global biopharma giants, Celgene and BMS, have announced a collaboration to advance cancer immunotherapies across multiple tumour types. The partnership will see the two companies study a combination of BMS’s anti-PD-1 drug Opdivo (nivolumab) … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap